John Samuelsson, PhD, is currently the Associate Director of AI/ML and Generative AI Lead at Pfizer, where they work on developing novel digital medicines and endpoints using advanced data analysis techniques. Previously, John served as a Principal Investigator and Postdoctoral Research Fellow at Harvard Medical School and Massachusetts General Hospital, securing NIH funding to develop innovative brain stimulation technology. They also spent five years as a Graduate Research Fellow at The MGH/HST Martinos Center for Biomedical Imaging, where they created computational methods for non-invasive neural assessments. Additionally, John holds a PhD in Medical Engineering and Medical Physics from the Massachusetts Institute of Technology and has contributed to various research projects during their academic journey.